Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Supermicrosurgical Lymphvenous Bypass Intervention for Lymphedema Treatment

NCT05270629 is registered in ClinicalTrials.gov with Chang Gung Memorial Hospital as lead sponsor.

NCT NCT05270629
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05270629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Supermicrosurgical Lymphvenous Bypass Intervention for Lymphedema Treatment
Lead sponsor
Chang Gung Memorial Hospital
Phase
Observational
Overall status
Unknown status
Start date
September 6, 2021
Completion date
September 5, 2022
Enrollment
87 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphedema of leg